Vijaykumar Nekkanti
Vijaykumar Nekkanti
Verified email at westernu.edu - Homepage
Title
Cited by
Cited by
Year
Insoluble drug delivery strategies: review of recent advances and business prospects
S Kalepu, V Nekkanti
Acta Pharmaceutica Sinica B 5 (5), 442-453, 2015
7492015
Solid self-microemulsifying formulation for candesartan cilexetil
V Nekkanti, P Karatgi, R Prabhu, R Pillai
Aaps Pharmscitech 11 (1), 9-17, 2010
1502010
Development and characterization of solid oral dosage form incorporating candesartan nanoparticles
V Nekkanti, R Pillai, V Venkateshwarlu, T Harisudhan
Pharmaceutical development and technology 14 (3), 290-298, 2009
732009
Improved delivery of poorly soluble compounds using nanoparticle technology: a review
K Sandeep, N Vijaykumar
Drug Delivery and Translational Research, 2016
432016
Spray-drying process optimization for manufacture of drug–cyclodextrin complex powder using design of experiments
V Nekkanti, T Muniyappan, P Karatgi, MS Hari, S Marella, R Pillai
Drug development and industrial pharmacy 35 (10), 1219-1229, 2009
432009
Proliposomes for Oral Delivery: Progress and Challenges
V Nekkanti, V Natarajan, G Betageri
Current Pharmaceutical Biotechnology 16 (4), 1-10, 2015
422015
Pharmacokinetic evaluation of improved oral bioavailability of valsartan: proliposomes versus self-nanoemulsifying drug delivery system
V Nekkanti, Z Wang, GV Betageri
AAPS PharmSciTech 17 (4), 851-862, 2016
382016
Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine
V Nekkanti, J Rueda, Z Wang, GV Betageri
International journal of pharmaceutics 505 (1-2), 79-88, 2016
372016
Recent Advances in Liposomal Drug Delivery: A Review
V Nekkanti, S Kalepu
Pharmaceutical Nanotechnology 3 (1), 35-55, 2015
312015
Drug nanoparticles–An overview
V Nekkanti, V Vabalaboina, R Pillai
The delivery of nanoparticles, 111-132, 2012
282012
Improved oral bioavailability of valsartan using proliposomes: design, characterization and in vivo pharmacokinetics
V Nekkanti, N Venkatesan, Z Wang, GV Betageri
Drug development and industrial pharmacy 41 (12), 2077-2088, 2015
262015
Media milling process optimization for manufacture of drug nanoparticles using design of experiments (DOE)
V Nekkanti, A Marwah, R Pillai
Drug development and industrial pharmacy 41 (1), 124-130, 2015
192015
Design, Characterization, and In Vivo Pharmacokinetics of Tacrolimus Proliposomes
GVB Vijaykumar Nekkanti, Javier Rueda, Zhijun Wang
AAPS PharmSciTech, 1-11, 2015
18*2015
Insoluble drug delivery technologies: review of health benefits and business potentials
B Siddalingappa, V Nekkanti, GV Betageri
OA Drug Design & Delivery 1 (1), 1, 2013
152013
Development of Novel Lipid Based Drug Delivery System for Raloxifene Hydrochloride
V Nekkanti, K Sandeep
International Research Journal of Pharmacy 3 (9), 166-173, 2012
142012
Development and characterization of solid oral dosage form incorporating candesartan nanoparticles
N Vijaykumar, P Raviraj, V Venkateshwarlu, T Harisudhan
Pharm. Dev. Tech 14, 290-298, 2009
142009
Development and pharmacological evaluation of a PEG based nanoparticulate camptothecin analog for oral administration
V Nekkanti, V Venkateswarlu, K Akhter Ansari, R Pillai
Current drug delivery 8 (6), 661-666, 2011
102011
Development of oral tablet dosage form incorporating drug nanoparticles
V Nekkanti, V Venkateswarlu, R Pillai
Research Journal of Pharmaceutical, Biological and Chemical Sciences 1 (4 …, 2010
10*2010
Nanoparticles for improved delivery of poorly soluble drugs
V Nekkanti, J Rueda
J. Drug 1 (1), 18-27, 2016
82016
Developing nanoparticle formulations of poorly soluble drugs
V Nekkanti, P Karatgi, M Joshi, R Pillai
Pharmaceutical Technology Europe 11, 24-28, 2008
82008
The system can't perform the operation now. Try again later.
Articles 1–20